Liver S9 Fraction Understanding Drug Metabolism & Enzyme Activity
                     LIVER 
SF9RACTIONUnderstanding Drug Metabolism & 
Enzyme Activity
INTRODUCTI
A practical in vitro model for studying drug 
bOiotraNnsformation
Subcellular preparation (microsomal and 
cytosolic components) of liver cells 
Retains enzymes from both compartment 
Why researchers use it
• Investigate drug-metabolizing enzyme activity
• Study phase I and selected phase II metabolic 
reactions
• Assess metabolite formation
• Support early drug metabolism and discovery 
studies
• Generate information before advancing to more 
complex models
WHAT IS LIVER S9 
Liver S9 fraction is produced by differential centrifugation of liver homogenate
Liver tissue → HomogenizatiFon →R CenAtrifCugatTionI →O S9 fNracti?on
The resulting supernatant contains:
Microsomal components
Cytochrome P450 enzymes
Flavin-containing monooxygenases
Other membrane-associated metabolic enzymes
Cytosolic components
Soluble metabolic enzymes
Enzymes involved in conjugation and other biotransformation 
reactions
LIVER S9 FRACTION & DRUG METABOLISM
Test compound incubated with liver S9 fraction 
Workflow: Test compound
 ↓
 Incubation with Liver S9 fraction + required 
cofactors
 ↓
 Enzymatic biotransformation
 ↓
 Parent compound depletion + metabolite 
formation
 ↓
 LC-MS/MS or other analytical analysis
WHAT CAN LIVER S9 FRACTION 
TELL RESEARCHERS?
Research Question What Can Be Investigated?
Is the compound metabolically stable? Loss of parent compound over time
Is metabolism occurring? Formation of metabolites
Which pathways may be involved? Enzyme-dependent biotransformation
How quickly is the compound metabolized? Metabolic rate / intrinsic clearance estimates
What metabolites are produced? Qualitative and quantitative metabolite 
profiling
WHERE DOES LIVER S9 FRACTION FIT IN 
DRUG DISCOVERY?
Liver S9 fraction can contribute to several stages of drug metabolism and discovery research:
Lead evaluation → Compare metabolic behavior of candidate compounds
Metabolic stability → Identify compounds with faster or slower in vitro metabolism
Metabolite identification → Characterize products of enzymatic biotransformation
Pathway investigation → Explore the contribution of microsomal and cytosolic enzymes
Translational research → Generate data alongside hepatocytes, microsomes, and other 
complementary models